New Online CourseThe FDA-led High Throughput Truthing (HTT) project [https://ncihub.cancer.gov/groups/eedapstudies/overview] created a 3.00 Credit Hour CME Course titled the Assessment of Stromal-Tumor Infiltrating Lymphocytes. Hosted on the FDA’s Continuing Education (CE) portal [https://ceportal.fda.gov/], the course introduces the clinical significance of stromal tumor-infiltrating lymphocytes (sTILs), gives an overview of how to perform and identify pitfalls in the sTILs assessment, and includes a manuscript by Salgado et al. (Annal Oncol., 2015) on TILs assessment recommendations by the International Immuno-Oncology Biomarker Working Group [www.tilsinbreastcancer.org].
To find the course: log into the portal - ceportal.fda.gov -- U.S. Food & Drug Administration-, click on “Online Learning”, and scroll down to our course. You can also use the search function in the “Online Learning” page to search for “Assessment”. courtesy of:Dr. Brandon D. Gallas U.S. Food and Drug Administration Center for Devices and Radiological Health Office of Science and Engineering Laboratories Division of Imaging, Diagnostics, and Software Reliability |
